中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/3495
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1514882      Online Users : 61
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > College of Medicine > School of Medicine > Journal articles >  Item 310903500/3495
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/3495


    Title: Clinical outcome of hepatitis C virus antibody-positive renal allograft recipients
    Authors: 黃秋錦(Chiu-Ching Huang);(YF Liaw);(MK Lai);(Chu SH);(Chuang CK);(Huang JY)
    Contributors: 醫學院醫學系學士班內科學科;中國附醫內科部腎臟科
    Date: 1992
    Issue Date: 2009-08-20 18:47:15 (UTC+8)
    Abstract: In order to investigate the prevalence of antibody to hepatitis C virus (anti-HCV) in renal transplant patients, the evolution of anti-HCV status, and clinical outcome in anti-HCV-positive renal allograft recipients, we tested the sera from 120 renal transplant patients for anti-HCV. Thirty-eight patients were hepatitis B surface antigen (HBsAg)-positive. Two patients were anti-delta-positive. A total of 79 patients (65.8%) had at least one serum positive for anti-HCV. Anti-HCV positivity decreased after transplantation for more than 5 years (65.5% at transplantation versus 37.9%, 78.3+/- 13.4 months later).

    Among those with positive anti-HCV, the HBsAg-pos-itive group had significantly higher incidence of chronic hepatitis (50% vs. 25.5%, P=0.026) and liver cirrhosis (21.4% vs. 0%, P=0.001) than HBsAg-negative group. Among the 82 HBsAg-negative patients, the prevalence of anti-HCV was significantly higher in those with chronic hepatitis than in those without (86.7% vs. 56.7%, P=0.027).

    We conclude from this study: (1) anti-HCV positivity is quite prevalent in renal transplant patients; (2) coinfection of hepatitis B virus (HBV) and hepatitis C virus (HCV) may lead to aggressive liver disease and cirrhosis; HCV infection alone has a more benign clinical outcome; and (3) HCV infection is an important cause of posttransplant chronic hepatitis in HBsAg-negative patients.

    (C) Williams & Wilkins 1992. All Rights Reserved.
    Relation: TRANSPLANTATION PROCEEDINGS53(53):763~765
    Appears in Collections:[School of Medicine] Journal articles

    Files in This Item:

    File SizeFormat
    0KbUnknown325View/Open


    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback